Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GVAX Pancreas (CG 8020 + CG 2505) in Advanced Pancreatic Cancer
NCT00245362Phase 2Completed
- Sponsor
- Cell Genesys
- Start
- Jun 2002
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GVAX pancreatic cancer vaccine in pancreatic adenocarcinoma (PDAC), sponsored by Cell Genesys. Started Jun 2002; status: completed.
02
Drugs
GVAX pancreatic cancer vaccine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00245362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245362.